Pelvic Floor Magnetic Stimulation in Women With Idiopathic Overactive Bladder (NCT04450511) | Clinical Trial Compass
CompletedNot Applicable
Pelvic Floor Magnetic Stimulation in Women With Idiopathic Overactive Bladder
Turkey (Türkiye)76 participantsStarted 2020-09-01
Plain-language summary
In clinical practice, Bladder Training (BT) and Magnetic stimulation (MS) are frequently used together in the treatment of women with idiopathic overactive bladder (OAB). Up to our knowledge, there is no study evaluating the combined effect of magnetic stimulation and bladder training in women with idiopathic OAB in the literature. Moreover, there is no recommendation on conservative treatment combinations in the guidelines due to insufficient data. At this stage, studies are needed to determine whether it will be effective to use MS in combination with other conservative treatment options. In addition, in the light of our clinical experience, we think that this issue is still open for research. In our study, adding MS to BT in women with idiopathic OAB is thought to contribute additionally to the efficacy of treatment with BT.
Our study is the first prospective randomized controlled trial that compares the efficacy of BT and BT plus MS in women with idiopathic OAB. In this study, we aimed to evaluate the efficacy of MS added to BT on incontinence-related QoL and clinical parameters in women with idiopathic OAB.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Women over the age of 18 with clinical diagnosis of idiopathic OAB
✓. Urodynamically confirmed detrusor overactivity (the presence of detrusor contractions in the filling phase of saline cystometry)
✓. Not tolerated or unresponsive to antimuscarinics and discontinued at least 4 weeks
✓. Able to give written, informed consent
✓. Able to understand the procedures, advantages and possible side effects
✓. Willing and able to complete the voiding diary and QoL questionnaire
✓. The strength of PFM 3/5 and more
Exclusion criteria
✕. History of BT, MS therapy
✕. Pregnancy or intention to become pregnant during the study
✕. Current vulvovaginitis or urinary tract infections or malignancy